Realistic expectationsPL dismissal should have been done a long time ago. He is leaving the company with no FDA approval, no partnership, no cash whatsoever and no viable short term options as reflected in the current SP and targets (TD = 0.30$). Remember that PLI confirmed that they need to sell shares at current price just to be able to cover payroll and keep the lights on. Closing over the holiday is a survival measure taken in crisis due to the lack of business activity, lack of revenues and the need to conserve cash. At best, I see a modest opportunity at some point in 2019 if they make progress with the FDA approval and get some modest partnership deal, for an uptick to maybe 0.60$. If they cannot get there due to lack of cash, a takeover at a bargain basement price is another option. Expectation of a homerun with this company should be forgotten. Their focus right now is just to survive. JIMO GLTA